Jim Faulkner BSc, PhD

Jim Faulkner joined Autolus from GlaxoSmithkline, where he spent 15 years in a series of progressively senior roles within the Biopharmaceutical R&D Unit, latterly serving as Vice President, Manufacturing and Supply within the GSK Rare Diseases unit. Jim’s role spanned all the unit’s projects and products including its ex vivo autologous gene therapy portfolio, therapeutic oligonucleotides and monoclonal antibodies.

Previously Jim worked within small biotech and has also held academic posts. He received a BSc in biotechnology from the University of Leeds and a PhD in molecular biology in association with the University of Kent and has authored a number of publications and patents in the field of biopharmaceutical development.